Anxiety and depression in women with endometriosis: a comparative study across fertility contexts

B Mathilde, Mathilde Bourdon, Bourdon M, Bourdon Mathilde, Laure Bolac, B. Laure, Bolac L, Celie Cervantes, Cervantes C, Cervantes Celie, Maignien Chloé, Maignien C, Chloé Maignien, Aoun-Clavel Rhea, Rhea Aoun-Clavel, Aoun-Clavel R, R. Marianne, Marianne Reynaud, Reynaud M, Catherine Patrat, Patrat C, Patrat Catherine, Chapron Charles, Charles Chapron, Chapron C, Piétro Santulli, Pietro Santulli
Fertility and sterility · 2025 · vol. 125(4) , pp. 688–697 · doi:10.1016/j.fertnstert.2025.12.011 · PMID:41419108 · W4417443201
Observational OA: hybrid CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Women with endometriosis undergoing IVF/ICSI showed significantly higher depression rates than controls, while women undergoing fertility preservation did not, with severe dyspareunia linked to anxiety and/or depression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To assess the prevalence of anxiety and depression in women with endometriosis undergoing ovarian stimulation and oocyte retrieval for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) or fertility preservation (FP) compared with women without endometriosis. DESIGN: Observational cohort study conducted in a university hospital-based research center. SUBJECTS: Women who underwent ovarian stimulation and oocyte retrieval between November 2023 and May 2024 for IVF/ICSI or nononcological FP. Two populations were analyzed: (i) infertile women undergoing IVF/ICSI as part of a current family-building project, and (ii) women undergoing oocyte vitrification for FP. EXPOSURE: Participants were classified as endometriosis (exposed) or disease-free (unexposed) based on imaging (transvaginal ultrasound and/or magnetic resonance imaging). All patients completed a 55-item questionnaire, including the validated Hospital Anxiety and Depression Scale (HADS), on the day of oocyte retrieval. MAIN OUTCOME MEASURES: Prevalence of anxiety and depression, defined as a HADS-A or HADS-D score ≥11. RESULTS: The study included 324 women: 196 IVF/ICSI patients (73 with endometriosis and 123 controls) and 128 FP patients (38 with endometriosis and 90 controls). Overall, 111/324 (34.3%) had endometriosis. Anxiety prevalence was higher in women with endometriosis in both populations, but did not reach significance. In patients undergoing IVF/ICSI, depression was significantly more frequent in those with endometriosis vs. controls (5.5% vs. 0.8%). In the FP population, women with endometriosis more often reported prior psychological support (21.1% vs. 4.4%) and psychotropic use (13.2% vs. 2.2%). Multivariate analysis identified severe deep dyspareunia as a factor independently associated with anxiety and/or depression (adjusted odds ratio 2.7; 95% confidence interval, 1.1-7.2). CONCLUSION: Among patients undergoing IVF/ICSI, depression was significantly more prevalent in women with endometriosis, whereas no significant difference was observed in the FP population. These findings underscore the importance of integrating psychological support into assisted reproductive technology management for women with endometriosis, particularly those experiencing severe pain and/or infertility.

My notes (saved in your browser only)

Condition tags

endometriosisdyspareuniainfertility

MeSH descriptors

Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety Anxiety

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (44)

Cited by (2)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-14T06:04:27.430825+00:00
License: CC0 · commercial use OK